Lgt Capital Partners Ltd. Syros Pharmaceuticals, Inc. Transaction History

Lgt Capital Partners Ltd.

  • $2.88 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 13, 2022
BUY
$0.69 - $1.21 $34,500 - $60,500
50,000 Added 10.0%
550,000 $529,000
Q4 2021

Jan 14, 2022
BUY
$3.26 - $4.66 $1.49 Million - $2.13 Million
456,612 Added 1052.39%
500,000 $1.63 Million
Q3 2021

Oct 13, 2021
BUY
$4.08 - $5.66 $177,023 - $245,576
43,388 New
43,388 $194,000

About Syros Pharmaceuticals, Inc.

SYRS Quotes by TradingView
  • Ticker SYRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,236,200
  • Market Cap $43.1M
  • Description
  • Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...
More about SYRS
Track This Portfolio

Track Lgt Capital Partners Ltd. Portfolio

Follow Lgt Capital Partners Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lgt Capital Partners Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Lgt Capital Partners Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email